Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 6540-6546

  Rothman, Alan L ^a   Kurane, Ichiro ^a   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; DENGUE; DENGUE VIRUS; HAPLOTYPE; HELPER CELL; HLA SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SUPPRESSOR CELL;

EID: 0029794372     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.6540-6546.1996     Document Type: Article

References (50)

1. Boonpucknavig, S., O. Vuttiviroj, and V. Boonpucknavig. 1981. Infection of young adult mice with dengue virus type 2. Trans. R. Soc. Trop. Med. Hyg. 75:647-653.
2. Bray, M., and C. J. Lai. 1991. Dengue virus premembrane and membrane proteins elicit a protective immune response. Virology 185:505-508.
3. Bray, M., B. Zhao, L. Markoff, K. H. Eckels, R. M. Chanock, and C. J. Lai. 1989. Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis. J. Virol. 63:2853-2856.
4. + human cytotoxic T lymphocytes. J. Virol. 63:5086-5091.
5. Burke, D. S., A. Nisalak, D. E. Johnson, and R. M. Scott. 1988. A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38:172-180.
6. Chaturvedi, U. C., R. Dhawan, M. Khanna, and A. Mathur. 1991. Breakdown of the blood-brain barrier during dengue virus infection of mice. J. Gen. Virol. 72:859-866.
7. Clerici, M., D. R. Lucey, R. A. Zajac, R. N. Boswell, H. M. Gebel, H. Takahashi, J. A. Berzofsky, and G. M. Shearer. 1991. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J. Immunol. 146:2214-2219.
8. Delenda, C., I. Staropoli, M. Frenkiel, L. Cabanie, and V. Deubel. 1994. Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice. J. Gen. Virol. 75:1569-1578.
9. Doherty, P. C. 1996. Cytotoxic T cell effector and memory function in viral immunity. Curr. Top. Microbiol. Immunol. 206:1-14.
10. Eisenlohr, L. C., J. W. Yewdell, and J. R. Bennink. 1992. A transient transfection system for identifying biosynthesized proteins processed and presented to class I MHC restricted T lymphocytes. J. Immunol. Methods 154:131-138.
11. Falgout, B., M. Bray, J. J. Schlesinger, and C.-J. Lai. 1990. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64:4356-4363.
12. Falgout, B., M. Pethel, Y. Zhang, and C. J. Lai. 1991. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J. Virol. 65:2467-2475.
13. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (London) 351:290-296.
14. + cytotoxic T-lymphocyte clones. J. Virol. 70:141-147.
15. Gigstad, J., et al. Unpublished data.
16. Gonzalez-Gay, M. A., E. Zanelli, C. J. Krco, G. H. Nabozny, J. Hanson, M. M. Griffiths, H. S. Luthra, and C. S. David. 1995. Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis. Immunogenetics 42:35-40.
17. + T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination. J. Virol. 67:5962-5967.
18. Guzman, M. G., G. P. Kouri, J. Bravo, M. Soler, S. Vazquez, and L. Morier. 1990. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 42:179-184.
19. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
20. Halstead, S. B. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 11:S830-S839.
21. Halstead, S. B. 1992. The XXth century dengue pandemic: need for surveillance and research. World Health Stat. Q. 45:292-298.
22. Hosmalin, A., M. Clerici, R. Houghten, C. D. Pendleton, C. Flexner, D. R. Lucey, B. Moss, R. N. Germain, G. M. Shearer, and J. A. Berzofsky. 1990. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 87:2344-2348.
23. - cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J. Virol. 65:1823-1828.
24. Kurane, I., and F. A. Ennis. 1992. Immunity and immunopathology in dengue virus infections. Semin. Immunol. 4:121-127.
25. Kurane, I., C. H. Hoke, Jr., K. H. Eckels, F. J. Malinoski, J. Janus, and F. A. Ennis. 1994. Activation of T lymphocytes after immunization with live attenuated experimental dengue virus vaccines: elevation of levels of soluble interleukin 2 receptor and soluble CD4 in plasma. Vaccine Res. 3:137-144.
26. Kurane, I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. Meager, J. Janus, and F. A. Ennis. 1991. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J. Clin. Invest. 88:1473-1480.
27. Kurane, I., B. L. Innis, A. Nisalak, C. Hoke, S. Nimmannitya, A. Meager, and F. A. Ennis. 1989. Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J. Clin. Invest. 83:506-513.
28. Kurane, I., A. Meager, and F. A. Ennis. 1989. Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J. Exp. Med. 170:763-775.
29. Kurane, I., Y. Okamoto, L. Dai, L. L. Zeng, M. A. Brinton, and F. A. Ennis. 1995. Flavivirus-cross-reactive, HLA-DR15-restricted epitope on NS3 recognized by human CD4+ CD8- cytotoxic T lymphocyte clones. J. Gen. Virol. 76:2243-2249.
30. Kurane, I., A. L. Rothman, P. G. Livingston, S. Green, S. J. Gagnon, J. Janus, B. L. Innis, S. Nimmannitya, A. Nisalak, and F. A. Ennis. 1994. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. 9:59-64.
31. Kutubuddin, M., A. S. Kolaskar, S. Galande, M. M. Gore, S. N. Ghosh, and K. Banerjee. 1991. Recognition of helper T cell epitopes in envelope (E) glycoprotein of Japanese encephalitis, West Nile, and dengue viruses. Mol. Immunol. 28:149-154.
32. Livingston, P. G., I. Kurane, L. Dai, Y. Okamoto, C. J. Lai, R. Men, S. Karaki, M. Takiguchi, and F. A. Ennis. 1995. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J. Immunol. 154:1287-1295.
33. - cytotoxic T-cell clones. J. Virol. 68:3283-3288.
34. Lukacher, A. E., L. A. Morrison, V. L. Braciale, B. Malissen, and T. J. Braciale. 1985. Expression of specific cytolytic activity by H-21 region-restricted, influenza virus-specific T lymphocyte clones. J. Exp. Med. 162:171-187.
35. d mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer. J. Immunol. 130:463-470.
36. Men, R., M. Bray, and C. J. Lai. 1991. Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice. J. Virol. 65:1400-1407.
37. Monath, T. P. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 91:2395-2400.
38. Morens, D. M. 1994. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin. Infect. Dis. 19:500-512.
39. Morrison, D. C., and J. L. Ryan. 1979. Bacterial endotoxins and host immune responses. Adv. Immunol. 28:293-450.
40. Morrison, L. A., V. L. Braciale, and T. J. Braciale. 1988. Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes. J. Immunol. 141:363-368.
41. Osatomi, K., and H. Sumiyoshi. 1990. Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology 176:643-647.
42. Roehrig, J. T., A. J. Johnson, A. R. Hunt, B. J. Beaty, and J. H. Mathews. 1992. Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J. Virol. 66:3385-3390.
43. + cytotoxic T lymphocytes. J. Virol. 67:801-806.
44. Rothman, A. L., I. Kurane, C. J. Lai, Y. Zhang, M. Bray, B. Falgout, B. Zhao, J. J. Schlesinger, and F. A. Ennis. 1990. Lymphocyte proliferative responses to dengue virus E and NS1 proteins in BALB/c mice, p. 135-138. In F. Brown, R. M. Chanock, H. Ginsberg, and R. A. Lerner (ed.), Vaccines 90: modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
45. Rothman, A. L., I. Kurane, Y. Zhang, C. J. Lai, and F. A. Ennis. 1989. Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins. J. Virol. 63:2486-2491.
46. Sangkawibha, N., S. Rojanasuphot, S. Ahandrik, S. Viriyapongse, S. Jatanasen, V. Salitul, B. Phanthumachinda, and S. B. Halsteud. 1984. Risk factors for dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120:653-669.
47. Schlesinger, J. J., M. W. Brundriss, and E. E. Walsh. 1987. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J. Gen. Virol. 68:853-857.
48. Shirai, M., H. Okada, M. Nishioka, T. Akatsuka, C. Wychowski, R. Houghten, C. D. Pendleton, S. M. Feinstone, and J. A. Berzofsky. 1994. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68:3334-3342.
49. Takahashi, H., J. Cohen, A. Hosmalin, K. B. Cease, R. Houghten, J. L. Cornette, C. DeLisi, B. Moss, R. N. Germain, and J. A. Berzofsky. 1988. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp 160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 85:3105-3109.
50. Zhao, B., G. Prince, R. Horswood, K. Eckels, P. Summers, R. Chanock, and C. J. Lai. 1987. Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus. J. Virol. 61:4019-4022.